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Description of the Clinical Problem
According to the National Cancer Institute approximately 1,735,350 Americans
will be diagnosed with cancer in 2018 (American Cancer Society, 2018) . It is estimated
that 30%-50% of those patients receiving treatment will experience pain caused by
malignancy or the cancer therapy itself. Regrettably, 70-90% of those with metastatic
disease will encounter severe discomfort, due most often to tumor burden at secondary
sites (Platt, 2010).
Uncontrolled pain is distressing and leads to poor functionality, decreased
emotional well-being, unplanned Emergency Department (ED) visits, and unanticipated
hospital admissions (UHA) (Numico et al., 2015; Rocque et al., 2013). For example,
from 2006-2012, 29.5 million (4.2%) adult Emergency Department (ED) visits were
attributed to uncontrolled oncologic symptoms (Rivera et al., 2017). The inability to
complete daily tasks including ambulation, dressing, feeding, and toileting of oneself
instigates fear and lack of self-control, resulting in depression and anxiety in one-quarter
of the population (Jacobsen & Jim, 2008). Further studies found those harboring
depressive symptoms in the setting of advanced cancer had a 25% increased risk of
mortality and were 4 times more likely to hasten death (Jacobsen & Jim, 2008).
A 2012-2016 study aimed at decreasing ED and hospital admissions found that
patients given an earlier palliative care referral (PCR) had 18.1% less ED visits and
12.5% less acute hospital admissions versus late PCRs (Michael et al., 2019). In response
to the evidence, the American Society of Clinical Oncology (ASCO) updated its
guidelines in 2016, recommending the integration of PC into standard oncology care:
“Patients with advanced cancer should be referred to interdisciplinary PC teams that
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provide inpatient and outpatient care early in the course of disease, alongside active
treatment of cancer” (Ferrell et al., 2017).
Assessing pain alone does not acknowledge the interconnectedness of
psychosocial, spiritual, and physical duress. To discount these relationships contributes
to insufficient treatment leading to unnecessary suffering, poor quality of life, and
inferior health outcomes.
A survey conducted amongst all physicians with patient care responsibilities,
belonging to the Easter Cooperative Oncology Group (ECOG), found 76% of oncologists
specified poor pain assessment as the most significant impediment to appropriate pain
management (Von Roenn, Cleeland, Gonin, Hatfield, & Pandya, 1993). Therefore, a
proper pain evaluation must be an essential component of the oncologic treatment plan.
This evaluation assists in determining pain severity as well as the extent of its physical
and emotional impact. With this tool, a clinician is more able to manage oncologic
symptoms in high-risk patients frequently utilizing the ED or are admitted to the hospital.
Description of Project, Eligibility Criteria, and Primary Aims
This project implemented an algorithmic approach to assess pain, functionality,
and psychosocial states in newly diagnosed cancer patients, utilizing a validated pain
tool, within a second-year-fellow Hematology/Oncology clinic, with intent to identify
patients at high-risk for ED admission or UHA.
The second-year-fellow Hematology/Oncology clinic site services approximately
450 patients per year. Clinic hours occurred on Thursday afternoons (1200-1600) during
a 3-month data collection period. Prior to this project, this site had not utilized a formal
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comprehensive pain assessment tool. Hence, baseline data on prior institutional
performance was not available.
To be eligible to participate within this study, patients needed have a new cancer
diagnosis or subsequent recurrence and were presenting for consultation prior to starting
treatment. Additionally, the patient had to have decision-making capacity as well as the
ability to independently communicate and read English at a fifth-grade level.
Primary aims for this project included: (a) aggregating demographic data to
determine the profile of a high-risk patient seen within this clinic, (b) determining those
referred to and who followed up with symptom specialists or the ED, and (c) identifying
barriers for next iteration of the project.
Secondary goals included: (a) assessing the effectiveness of a Comprehensive
Pain Assessment tool in helping to identify pain, psychosocial, functional, spiritual
distress, and substance abuse potential in patients newly diagnosed with cancer, (b)
providing thorough education on pharmacological and nonpharmacological modalities to
reduce pain, (c) explaining the purpose and misconceptions of PC, and (d) managing
symptoms and/or providing referrals for appropriate interventions in a timely manner to
improve patient satisfaction and health outcomes.
Project Plan Process
Following stakeholder and IRB approval, a provider documentation template in
the electronic medical record (EMR) was created. Information within the note was based
on a validated Adult Oncology Outpatient Comprehensive Pain Assessment Tool.
During data collection, a weekly chart review was completed by the investigator
to identify patients for consultation and confirmed with the consulting oncologist. Prior
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to assessment, patients were given an Information Letter for Research explaining the
intentions of the project and that involvement was voluntary (Appendix A).
The pain assessment was administered by the investigator during the patient
encounter. If a need for pain or symptom management, mental health services, social
work, or nurse navigation was identified, referrals were provided during that visit.
At the conclusion of the data collection period, the investigator performed a chart
review of all eligible patients, aggregating and analyzing data. Additionally, a postimplementation survey was conducted amongst the second-year fellows. Upon the
completion of both patient and physician data analysis, potential improvements to the
process were determined and presented to stakeholders.
Project Site
The site in which this project was conducted had recently merged with a worldrenowned cancer center. To comply with the cancer center’s standards, specific
oncologic algorithms and protocols are to be adopted into practice over an unspecified
time. For this reason, the Adult Oncologic Comprehensive Pain Assessment was
accepted as a validated tool by the facilitators without difficulty.
Framework
The Plan Do Check Act (PDCA) model, also known as the Shewart or Deming
cycle, is a highly-utilized tool in continuous process improvement (CPI). The
investigator must plan an intervention to a problem using evidenced-based practice, do
the necessary steps to achieve the potential solution, check the outcome(s) of the
implemented intervention, making necessary revisions, and then act on the revisions by
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implementing the best solutions. Ideally, this sequence should persist until the desired
outcome has been achieved (Johnson, 2002).
The Planning phase consisted of the project proposal to stakeholders,
development of project materials, and IRB application with approval. In the Do phase,
the eligible patients were identified, the Comprehensive Pain Assessment was
administered, and data were collected over 3 months. Data analysis and manuscript
development by the investigator occurred during the Check phase. Final data were
presented to stakeholders at the conclusion of the project to collect feedback on
identifiable barriers and potential iterations for next the attempt. Finally, the Act phase
required the agreed-upon revisions to be completed on the next PDCA cycle. This PDCA
framework was chosen to assist in the execution of the project due to its ease of
application, pertinence in the clinical environment, and familiarity within the institution
where the intervention was implemented.
Project Approval and Timeline
Initial project approval was obtained by presenting an implementation outline,
and evidence supporting the importance of comprehensive pain assessment in newly
diagnosed oncology patients to the providers on August 6, 2018 (Appendix B). An IRB
application was submitted to the health care organization on September 28, 2018.
Approval was obtained on November 15, 2018. An application for IRB approval from
the University of San Diego was subsequently submitted and approved by December 4,
2018 (Appendix C-D).
The 3-month data collection period commenced on December 6, 2018. Patients
were seen by the investigator in clinic every Thursday afternoon until February 28, 2019.
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At the conclusion of this period, chart reviews were performed on eligible patients
and data were analyzed for the next 21 days. A post-implementation survey was given to
all second-year fellows for feedback.
Stakeholders
The project data, evaluation, and communication plan were discussed at length
and unanimously agreed upon in an initial meeting with all stakeholders. A projected
timeline of 4 months from the creation of a standardized EMR-provider note to
completion of data collection was established. Regular meetings with the stakeholders
were scheduled to discuss progress, obstacles, and potential solutions. Outcomes were
also shared with five patients who were screened over the 3-month period.
Databases and Search Terms
PubMed, UpToDate, and Google Scholar were databases searched to identify
high-risk patient literature utilizing standardized comprehensive pain assessment to
reduce ED visits and hospital admissions. Further, these publications were evaluated for
the improvement of quality of care, patient satisfaction, and health outcomes. Common
search terms included oncology, pain, oncologic pain, assessment, palliative care, and
symptom management. At the conclusion of the literary search, 118 articles were
critically reviewed. Twelve of those articles were used for supporting evidence for this
project.
Evidenced-Based Solutions
Standardized Electronic Medical Record (EMR) Provider Documentation
In the United States, it is commonplace for large-scale, academic medical
practices to utilize an EMR system. In addition to improved documentation, it is also a
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helpful tool to assist in the identification of desired patient populations. Further, the EMR
can alert the clinician to screen specific high-risk populations and place appropriate,
timely orders.
The clinic utilized the EPIC EMR system in which this intervention was
employed. A provider documentation note template was created and replicated the
information required on the Comprehensive Pain Assessment Tool. The note could be
utilized by all EPIC users by typing the shortcut “COMPPAIN.” The template was
designed to self-populate patient information including name, date of birth, age, medical
record number, sex, diagnosis, medications, and allergies. Additionally, all assessment
questions related to pain, functionality, and psychosocial issues were listed as they
appeared on the original tool. Free text could be entered into the plan and assessment
portion of the record. A disclaimer explaining that the patient had been given literature
prior to the assessment and verbally consented to the study concluded the documentation.
Comprehensive Pain Assessment for High-Risk Patients
The Adult Oncology Outpatient Comprehensive Pain Assessment was developed
from evidenced-based literature and was designed specifically for the adult outpatient
oncology population, not including pregnant women. This tool not only assessed the
patient’s current level of pain, but also past and present psychosocial states, perceived
functionality in completing activities of daily living, expectations of pain control, and
potential problems with addiction (Appendix E).
Clinician Education
A 10-minute meeting with the second-year fellows was held prior to project
implementation explaining the importance of a comprehensive pain assessment in the
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outpatient adult oncology population as early in the diagnosis as possible. An electronic
notice summarizing the project, patient eligibility criteria, process of identifying eligible
patients, and project timeline was sent to all stakeholders prior to data collection.
Process and Outcome Indicator Data Monitoring
Chart Review
During the data collection period, the patient panel was reviewed every Thursday
morning to identify eligible patients from the new consultations. Findings were then
discussed and agreed upon with the oncologist treating the patient. Additionally, all
eligible patients’ charts were reviewed both during and at the conclusion of data
collection to determine if and when they followed up, presented to the ED, or were
unexpectedly hospitalized.
Post-Implementation Clinician Survey
The second outcome indicator for data monitoring included a 5-question survey
sent to the three fellows 1-week post data collection. The survey was relayed and
returned through a confidential email system (Table 1).
Table 1
Post-Implementation Clinician Survey Results
Yes

No

Cannot
Determine

Benefited your newly diagnosed patients?

3

0

0

Was an efficient and effective use of time?

3

0

0

Improved your patients’ outcome?

2

0

1

Improved your patients’ perceived quality of care?

3

0

0

Do you feel the Comprehensive Pain Assessment:
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Data Analysis
Aim 1: Demographic Information
During the 3-month data collection period, 121 patients were seen. Of those
patients, 56 were new consultations and 14 fit eligibility criteria. The Comprehensive
Pain Assessment Tool was administered to 5 of those patients (Figure 1).

140

121

120
100
56

80
60

14

40

5

20
0

Total Patients

Total Consults

Total Eligible
Patients

Total Patients
Seen

Figure 1. Number of patients and consultations.
Of the 14 eligible patients 4 were male and 10 were female. Median age was 70
years old with an age range of 56-90 years old. The most prominently diagnosed cancers
were Stage IV breast and gynecological malignancies. Four patients were not
pathologically diagnosed or staged at the time of the first consultation. Of the five
patients administered the pain assessment, 100% of them were female with Stage IV solid
tumor primary malignancies (Table 2).
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Table 2
Demographic Information Data Analysis
Not Seen (%)

Consulted (%)

(n = 9)

(n = 5)

Gender
Male

4 (44%)

Female

5 (56%)

5 (100%)

≤ 70 years

6 (67%)

1 (20%)

≥ 70 years

3 (33%)

4 (80%)

Median Age

69.9

71.4

Range

56-90

61-80

Age

Site of Primary Cancer
Breast

2 (22%)

Gynecological
Gastroenterological

3 (60%)
1 (11%)

Hepatocellular Carcinoma

1 (20%)

Skin (BCC of chest)

1 (11%)

Nerve Sheath Tumor

1 (11%)

Unknown

3 (33%)

Loss to Follow UP

1 (11%)

1 (20%)

Stage
I
II
III
IV

4 (44%)

2 (40%)

Unknown

5 (55%)

3 (60%)
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Aim 2: Baseline Data
Eighty-six percent of patients were correctly identified as being high-risk. Three
of the five patients administered the pain assessment were given PC referrals and
subsequently followed up. One patient was referred to a nurse navigator and had been
contacted by the service. One of the patients referred to PC was appropriately placed on
hospice and expired according to her wishes within 48 hours of completing Advanced
Directive and Physician Order for Life Sustaining treatment forms. One of the 5 patients
not referred was admitted to the ED and hospitalized (Table 3)
Table 3
Hospitalizations and Emergency Department (ED) Visits

Number of ED Admissions
1
2
3
≥4
Reason for ED Visit
Pain
Shortness of Breath
Other
Number of Unanticipated
Hospitalizations
1
2
3
≥4
Reason for Unanticipated
Hospitalization
Pain
Shortness of Breath
Other

Not Seen (%)
(n = 9)

Consulted (%)
(n = 5)

1 (11%)

2 (40%)
1 (20%)

1 (11%)

6 (67%)

1 (20%)
1 (20%)
1 (20%)

2 (22%)

1 (20%)

1 (11%)
1 (11%)

1 (20%)
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Three of the five patients administered the comprehensive pain assessment tool
presented to the ED and were hospitalized. Two of the nine patients not seen were
admitted to the ED and hospitalized. The most prominent causes for ED admission were
shortness of breath and pain. One patient who was identified as an eligible, high-risk
patient was not referred by the oncologist because they believed the patient appeared to
be “too overwhelmed.” Unfortunately, this patient had four ED admissions and one
hospitalization related to shortness of breath.
Aim 3: Barriers and Potential Solutions
After completion of the data collection period and subsequent analysis, several
barriers were recognized. The first obstacle to this study was a small sample size. As the
data suggested, solid tumor as well as breast and gynecological cancers were the most
prevalent. A potential solution may be to implement this intervention in a solid tumor
clinic such as breast, gynecology oncology, gastrointestinal, prostate, or lung.
The second barrier was under-consultation of eligible patients. Possible reasons
for this may have been a lack of clarity on patient eligibility criteria, miscommunication
on the purpose of assessing not only pain but psychosocial and functional states, the
physician’s belief that the patient did not require the intervention, or the patient refused
the intervention. On the next iteration of this project, a more in-depth presentation and
education on patient eligibility criteria, how to better identify high-risk patients, and the
components of the pain assessment tool should be provided to both providers and medical
assistants responsible for rooming the patients. Additionally, to avoid patients’ refusal
due to feeling overwhelmed on their first visit, assessing the patient within the first three
visits should be considered.
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The third hinderance was the lack of a dedicated space for consultation. The
Hematology Oncology clinic in which this project was implemented had limited patient
rooms and private space. A quiet, comfortable area with ample seating, space for
literature, and a computer would be an ideal location to conduct such a visit. An exam
room would be helpful should a more in-depth physical evaluation to assess pain and/or
functionality be required; however, it is not necessary as these patients had just been
examined by the oncologist. Additionally, it would be helpful for the investigator to be in
or around the oncologists during clinic hours. This would allow for discussion of patient
needs and unanticipated issues.
The fourth short-coming was the inability to assess patient satisfaction and health
outcomes. Due to the limited 3-month data collection period, it was difficult to determine
long-term health outcomes of early PC or mental health referrals, as well as their effect
on patient satisfaction. In the next cycle, a pre and post patient satisfaction survey is
recommended. Additionally, following the patients longitudinally over a 12- to 24month period would allow for a clearer understanding of the impact on decreasing ED
visits and unintentional hospitalizations.
Cost Analysis
The average cost of an oncologic ED visit in the United States is approximately
$1,127 (Rivera et al., 2017). During the 3-month data collection period, three out of five
consulted patients presented to the ED. Two patients presented once and one patient
presented twice. The estimated cost for all four ED visits was $4,508.
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Out of the nine patients not consulted, two presented to the ED. One patient
presented twice and one patient presented four times. The cost for all 6 ED visits equates
to $6,762.
It is the goal to apply iterations to this project, via the PDCA cycle, to achieve the
intention of identifying high-risk patients early on in treatment and providing
preventative interventions to reduce ED visits and hospital admissions. Had this been
accomplished, the potential savings would have been $11,270 in health care costs.
Dissemination
At the conclusion of this 3-month pilot, a stakeholder presentation exhibiting data
and outcomes was presented to at the Hematology/Oncology Division rounds on April 5,
2019. On April 13, 2019, a poster presentation of the project was presented at the 52nd
annual Western Institute of Nursing (WIN) Conference held at the Town and Country
Convention Center in San Diego, CA (Appendix F-G).
Sustainability
The institution in which this EPB project was conducted has an Internal Medicine
Residency Program and various fellowship programs. To extend and improve this
project, the current plan is for a resident, fellow, or DNP student to continue with the
initiative, implementing the discussed iterations. Projects such as this one can improve
the quality of care for oncology and/or PC patients.
Conclusion
This project implemented an algorithmic approach to assess pain, functionality,
and psychosocial states in newly diagnosed cancer patients. This was accomplished by
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utilizing a validated pain assessment tool for the purpose of identifying high-risk patients
for ED admission or UHA within a second-year fellow Hematology/Oncology clinic.
Eighty-six percent of patients were correctly identified as being high-risk for ED
or hospital admission. The average time to perform the comprehensive pain assessment
was approximately 23 minutes. Four out of the five consulted patients were not familiar
with the term or functions of palliative care.
Future iterations include (a) implementing this project within a solid tumor clinic,
with particular consideration to breast and gynecological malignancies; (b) providing
more information on eligibility criteria for providers determining a designated space for
consultation; (c) performing the consult within one to three visits of diagnosis; (d)
administering a pre and post implementation survey for patients and providers; and, (e)
following patients longitudinally for 6 months or greater.
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